|
|
|
|
HydralazinePharmaLive.com (press release), 12, 2005 - According to a pharmacoeconomic analysis titled "Cost-Effectiveness of Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine Therapy for ... NitroMed Promotes Michael Sabolinski, MD to the Position of Chief ... Jan 6, 2006 Genetic Engineering News, ...and participate in certain key decision making processes relative to the development of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) outside of ... NAACP and NitroMed Announce Partnership to Narrow Disparities in ... Dec 14, 2005 PharmaLive.com (press release), NitroMed is the maker of BiDil(R) (isosorbide dinatrate/ hydralazine HCl), a prescription medicine approved this year by the Food and Drug Administration (FDA ... NitroMed to Present at 24th Annual JPMorgan Healthcare Conference Jan 4, 2006 Genetic Engineering News, ...of Lexington, Massachusetts is a research-based emerging pharmaceutical company and the maker of BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride), an ... Major new medication promising for black heart patients Jan 2, 2006 Fort Lauderdale Sun Sentinel, The two drugs -- hydralazine hydrochloride and isosorbide dinitrate -- increase nitric oxide that relaxes and dilates blood vessels to improve blood flow. ... A cost effective heart failure drug hits the market! Dec 17, 2005 MedIndia, The comparison was made in patients who took a medication with two active drug ingredients, isosorbide dinitrate and hydralazine (ISDN/HYD), to those in ... NitroMed and Boston Scientific Complete Research Collaboration Dec 29, 2005 Finanzen.net, ...of Lexington, Massachusetts is a research-based emergingpharmaceutical company and the maker of BiDil(R) (isosorbidedinitrate/hydralazine hydrochloride), an ... Heart Failure Drug for Blacks a Good Deal Dec 13, 2005 Forbes It is actually a combination of two older drugs -- hydralazine, an anti-hypertensive agent that relaxes the arteries, and isosorbide dinitrate, an anti-anginal ... Study says heart drug for blacks cuts costs Dec 12, 2005 Pittsburgh Post Gazette, ...because the maker, NitroMed Inc., won 13 years of patent protection for a combination of two old drugs -- isosorbide dinitrate and hydralazine -- available in ... |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |